-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Kpxylxy+LTIgCDSakxgOsmtgelMUs/UxNBZClBUZHYWntgZv26HymgchmgoR+USe 9PZHJC0TrGDEuPzRZMjl8g== 0000893877-00-000027.txt : 20000202 0000893877-00-000027.hdr.sgml : 20000202 ACCESSION NUMBER: 0000893877-00-000027 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20000114 EFFECTIVENESS DATE: 20000114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICALOGIC INC CENTRAL INDEX KEY: 0000923899 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 930890696 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: SEC FILE NUMBER: 333-94761 FILM NUMBER: 508103 BUSINESS ADDRESS: STREET 1: 20500 NW EVERGREEN PARKWAY STREET 2: STE 400 CITY: HILLSBORO STATE: OR ZIP: 97124 BUSINESS PHONE: 5036456442 MAIL ADDRESS: STREET 1: 20500 NW EVERGREEN PARKWAY CITY: HILLSBORO STATE: OR ZIP: 97124 S-8 1 FORM S-8 As filed with the Securities and Exchange Commission on January 14, 2000 Registration No. 333-_____ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------- Form S-8 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 -------------- MEDICALOGIC, INC. (Exact name of registrant as specified in its charter) -------------- OREGON 93-0890696 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) -------------- 20500 NW EVERGREEN PARKWAY HILLSBORO, OREGON 97124 (503) 531-7000 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) MEDICALOGIC, INC 1999 STOCK INCENTIVE PLAN (Full title of plan) MARK K. LEAVITT CHIEF EXECUTIVE OFFICER 20500 NW EVERGREEN PARKWAY HILLSBORO, OREGON 97124 (503) 531-7000 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: TODD A. BAUMAN Stoel Rives LLP 900 SW Fifth Avenue, Suite 2600 Portland, Oregon 97204-1268 (503) 224-3380
CALCULATION OF REGISTRATION FEE - ----------------------------------------------------------------------------------------- Proposed Proposed Maximum Maximum Amount Amount Offering Aggregate of Regis- Title of Securities to Be Price Per Offering tration to Be Registered Registered Share (1) Price (1) Fee - ------------------- ---------- --------- ----------- --------- Common Stock 1,500,000 shares $14.7584 $22,137,638 $5,845 - ----------------------------------------------------------------------------------------- (1) The proposed maximum offering price per share and proposed maximum aggregate offering price were estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) and Rule 457(c) under the Securities Act of 1933. The calculation of the registration fee is based on (a) with respect to 1,593,450 shares reserved for issuance under the 1999 Stock Incentive Plan (the "Plan"), the exercise prices of outstanding options granted under the Plan as follows: Number of Shares Exercise or Purchase Price ---------------- -------------------------- 10,750 $ 6.50 560,000 $ 9.50 172,000 $10.00 350,700 $13.00 and (b) with respect to the remaining 406,550 shares reserved for issuance under the Plan, the average of the high and low prices of the common stock on the Nasdaq National Market for January 7, 2000.
PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3. Incorporation of Documents By Reference. The following documents filed by MedciaLogic, Inc. (the "Registrant") with the Securities and Exchange Commission are incorporated herein by reference: (a) The Registrant's latest annual report filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 or the latest prospectus filed pursuant to rule 424(b) under the Securities Act of 1933 that contains audited financial statements for the Registrant's latest fiscal year for which such statements have been filed. (b) All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 since the end of the fiscal year covered by the annual report or prospectus referred to in (a) above. (c) The description of the authorized capital stock of the Registrant contained in the Registrant's registration statement filed under Section 12 of the Securities Exchange Act of 1934, as amended, including any amendment or report filed for the purpose of updating the description. All reports and other documents subsequently filed by the Registrant pursuant to Sections 13(a) and (c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended, prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of the filing of such reports and documents. Item 4. Description of Securities. Not Applicable. Item 5. Interests of Named Experts and Counsel. Stoel Rives LLP, Portland, Oregon, holds a warrant to purchase 10,000 shares of Registrant's common stock at an exercise price of $6.50 a share. Partners and employees of Stoel Rives LLP beneficially own an aggregate of 47,000 shares of the Registrant's common stock. II-1 Item 6. Indemnification of Directors and Officers. Article IV of the Registrant's Restated Articles of Incorporation requires indemnification of current or former directors of the Registrant to the fullest extent not prohibited by the Oregon Business Corporation Act. The Oregon Business Corporation Act permits or requires indemnification of directors and officers in certain circumstances. The effects of the indemnification provisions are as follows: (a) The indemnification provisions grant a right of indemnification in respect of any proceeding (other than an action by or in the right of the Registrant) if the person concerned acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Registrant, was not adjudged liable on the basis of receipt of an improper personal benefit and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of a proceeding by judgment, order, settlement, conviction or plea of nolo contendere, or its equivalent, is not, of itself, determinative that the person did not meet the required standards of conduct. (b) The indemnifications provisions grant a right of indemnification in respect of any proceeding by or in the right of the Registrant against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred, provided the person concerned acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Registrant, except that no right of indemnification will be granted if the person is adjudged to be liable to the Registrant. (c) Every person who has been wholly successful, on the merits or otherwise, in the defense of any proceeding to which the person was a party because of the person's status as a director or officer is entitled to indemnification as a matter of right. (d) Because the limits of permissible indemnification under Oregon law are not clearly defined, the indemnification provisions may provide indemnifications broader than that described in (a) and (b). (e) The Registrant may advance to a director or officer the expenses incurred in defending any proceeding in advance of its final disposition if the director or officer affirms in writing in good faith that he or she has met the standard of conduct to be entitled to indemnification as described in (a) or (b) above and undertakes to repay any amount advanced if it is determined that the person did not meet the required standard of conduct. The Registrant has obtained insurance for the protection of its directors and officers against any liability asserted against them in their official capacities. The rights of II-2 indemnification described above are not exclusive of any other rights of indemnification to which the persons indemnified may be entitled under any bylaw, agreement, vote of shareholders or directors or otherwise. Item 7. Exemption From Registration Claimed. Not Applicable. Item 8. Exhibits. 4.1 1999 Restated Articles of Incorporation of the Registrant (incorporated by reference to Exhibit 4.1 to the Registrant's Registration Statement on Form S-8 (Registration No. 333-94751)). 4.2 Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant's Registration Statement on Form S-1, as amended (Registration No. 333-87285)). 5.1 Opinion of Stoel Rives LLP. 23.1 Consent of KPMG LLP. 23.2 Consent of KPMG LLP. 23.3 Consent of Stoel Rives LLP (included in Exhibit 5.1). 24.1 Power of Attorney (included on signature page) Item 9. Undertakings. (a) The Registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent II-3 post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement. (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; PROVIDED, HOWEVER, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement. (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. (b) The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that II-4 in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. II-5 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hillsboro, State of Oregon on January 14, 2000. MEDICALOGIC, INC. By MARK K. LEAVITT -------------------------------------- Mark K. Leavitt, M.D. Chief Executive Officer Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-8 has been signed below by the following persons in the capacities indicated on January 14, 2000. POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, an officer and/or director of MedicaLogic, Inc., does hereby constitute and appoint Mark K. Leavitt and David C. Moffenbeier his true and lawful attorney and agent to do any and all acts and things and to execute in his name (whether on behalf of MedicaLogic, Inc., or as an officer or director of said Registrant, or otherwise) any and all instruments which said attorney and agent may deem necessary or advisable in order to enable MedicaLogic, Inc. to comply with the Securities Act of 1933, as amended, and any requirements of the Securities and Exchange Commission in respect thereof, in connection with the registration under the Securities Act of 1933, as amended, of 2,000,000 shares of Common Stock of MedicaLogic, Inc., issuable pursuant to the 1999 Stock Incentive Plan, including specifically, but without limitation thereto, power and authority to sign his name (whether on behalf of MedicaLogic, Inc., or as an officer or director of said Registrant, or otherwise) to a Registration Statement on Form S-8 and any amendment thereto (including any post-effective amendment) or application for amendment thereto in respect to such Common Stock or any exhibits filed therewith; and to file the same with the Securities and Exchange Commission; and the undersigned does hereby ratify and confirm all that said attorney and agent shall do or cause to be done by virtue hereof. Signature Title --------- ----- MARK K. LEAVITT ------------------------------- Chairman of the Board Mark K. Leavitt, M.D. and Chief Executive Officer Principal Executive Officer II-6 FRANK J. SPINA ------------------------------- Senior Vice President Frank J. Spina and Chief Financial Officer Principal Financial and Accounting Officer BRUCE M. FRIED ------------------------------ Director Bruce M. Fried RONALD H. KASE ------------------------------ Director Ronald H. Kase DAVID C. MOFFENBEIER ------------------------------ Director David C. Moffenbeier NEAL MOSZKOWSKI ------------------------------ Director Neal Moszkowski MARK A. STEVENS ------------------------------ Director Mark A. Stevens RONALD R. TAYLOR ------------------------------ Director Ronald R. Taylor ------------------------------ Director David W. Wroe II-7 EXHIBIT INDEX Exhibit Number Document Description - ------- -------------------- 4.1 1999 Restated Articles of Incorporation of the Registrant. (incorporated by reference to Exhibit 4.1 to the Registrant's Registration Statement on Form S-8 (Registration No. 333-94751)). 4.2 Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant's Registration Statement on Form S-1, as amended (Registration No. 333-87285)). 5.1 Opinion of Stoel Rives LLP. 23.1 Consent of KPMG LLP. 23.2 Consent of KPMG LLP. 23.3 Consent of Stoel Rives LLP (included in Exhibit 5.1). 24.1 Power of Attorney (included on signature page) EX-5.1 2 OPINION OF STOEL RIVES LLP Exhibit 5.1 January 14, 2000 Board of Directors MedicaLogic, Inc. 20500 NW Evergreen Parkway Hillsboro, Oregon 97124 We have acted as counsel for MedicaLogic, Inc., (the "Company") in connection with the filing of a Registration Statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended, covering the issuance of 1,500,000 shares of common stock (the "Shares") of the Company pursuant to the Company's 1999 Stock Incentive Plan (the "Plan"). We have reviewed the corporate actions of the Company in connection with this matter and have examined those documents, corporate records, and other instruments we deemed necessary for the purposes of this opinion. Based on the foregoing, it is our opinion that: 1. The Company is a corporation duly organized and validly existing under the laws of the state of Oregon; and 2. The Shares have been duly authorized and, when issued in accordance with the Plan and in accordance with the resolutions adopted by the Board of Directors of the Company, will be legally issued, fully paid, and nonassessable. We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. Very truly yours, STOEL RIVES LLP STOEL RIVES LLP EX-23.1 3 CONSENT OF KPMG LLP EXHIBIT 23.1 Consent Of Independent Auditors The Board of Directors MedicaLogic, Inc.: We consent to incorporation by reference in the Registration Statement on Form S-8 of MedicaLogic, Inc. of our report dated October 22, 1999, except as to note 13(d), which is as of November 12, 1999 relating to the consolidated balance sheets of MedicaLogic, Inc. and subsidiaries as of December 31, 1997 and 1998, and September 30, 1999 and the related consolidated statements of operations, shareholders' equity (deficit) and cash flows for each of the years in the three-year period ended December 31, 1998 and for the nine-month period ended September 30, 1999 which report appears in the Form S-1 of MedicaLogic, Inc. (No. 333-87285). KPMG LLP Portland, Oregon January 11, 2000 EX-23.2 4 CONSENT OF KPMG LLP EXHIBIT 23.2 Consent Of Independent Auditors The Board of Directors MedicaLogic, Inc.: We consent to incorporation by reference in the Registration Statement on Form S-8 of MedicaLogic, Inc. of our report dated July 23, 1999 relating to the balance sheet of PrimaCis Health Information Technology, Inc. as of December 31, 1998, and the related statements of operations, stockholders' deficit and cash flows for the year ended December 31, 1998, which report appears in the Form S-1 of MedicaLogic, Inc. (No. 333-87285). KPMG LLP Portland, Oregon January 11, 2000 -----END PRIVACY-ENHANCED MESSAGE-----